CD19 CAR T‐Cell Therapy in Richter Transformation: A Multicentre Retrospective Analysis by the European Research Initiative on Chronic Lymphocytic Leukaemia
Ofrat Beyar‐Katz(Rambam Health Care Campus), Yair Herishanu(Tel Aviv University), Julio Delgado(Departament de Salut), Massimo Gentile(Azienda Ospedaliera di Cosenza), Sigal Grisariu(Hebrew University of Jerusalem), Avichai Shimoni, Ronit Marcus(Sheba Medical Center), Tamar Tadmor(Bnai Zion Medical Center), Giulia Gabrielli(Hospital of the University of Pennsylvania), Batia Avni(Hadassah Medical Center), Lydia Scarfò(IRCCS Ospedale San Raffaele), Roni Shouval(Memorial Sloan Kettering Cancer Center), Guido Ghilardi(Hospital of the University of Pennsylvania), Andrea Visentin(University of Padua), Κώστας Σταματόπουλος(Centre for Research and Technology Hellas), Luca Paruzzo(Hospital of the University of Pennsylvania), Noga Shem‐Tov(Tel Aviv University), Valentín Ortiz‐Maldonado(Hospital Clínic de Barcelona), Riva Fineman(Rambam Health Care Campus), Ohad Benjamini(Sheba Medical Center), Ron Ram(Tel Aviv University), Odelia Amit(Tel Aviv University), Abraham Avigdor(Sheba Medical Center), Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Ronit Leiba(Rambam Health Care Campus), Núria Martínez‐Cibrián(Hospital Clínic de Barcelona), Eva Minga(Centre for Research and Technology Hellas), Elisabeth Vandenberghe(Trinity College Dublin), Stephen J. Schuster(Hospital of the University of Pennsylvania), Ronit Yerushalmi(University of Colorado Boulder), Paolo Ghia(Vita-Salute San Raffaele University), Marco Ruella(Parker Institute for Cancer Immunotherapy), Ivetta Danylesko(Sheba Medical Center), Arnon Nagler(Tel Aviv University), Tsila Zuckerman(Johannes Gutenberg University Mainz)
Cited by 3
Related Papers
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
|New England Journal of Medicine|2014|1.1k